Stroke Dir @UChicago_Neuro | Former @BrainWavesAudio Prod. (RIP) | @GreenJournal Dep. Ed. | @SVINJournal Digital Strat. Team | #FOAM | Jimdominals @onepeloton

Chicago, IL
Joined November 2018
Like Winter in Chicago 🥶 the October CASPR update has arrived! 🎃 ✴️45% to goal!🪅 Top enrolling sites: 🥇Colorado: 211! 🥈Yale: 128! 🥉Grady: 67! Way to go! Special thanks to @SetarehOmranMD @NeeharikaThott1 @DineshJillella @aboulnourh for such success with enrollments!! 👏🏼
3
3
1
16
9,096
Friendly reminder to my colleagues in JACKSON, MISSISSIPPI, I'll be heading your way soon to discuss the shift in secondary prevention for STROKE. We welcome you to join us for a dinner + discussion regarding the effectiveness and implementation of novel FACTOR XI inhibitors.
1
1
331
⏰ When? Oct 27, 2026 7pm-9pm ‍👩‍🍳Where? Eastover Room at Char, Jackson, MS 🙏Compensation? $500 for participation (+ dinner) Event is sponsored by @neurology_live and @HCPLiveNews. 👏👏
1
1
155
Evidence that AI won’t replace us 👇🏼 Generative, evidence-based AI still requires CLINICIAN SCIENTISTS to produce original research to provide high quality syntheses of information. Thank you @OpenEvidence @NEJM! @ShadiYaghi2 @RichaSharmaMD
1
1
13
4,824
The latest CASPR manuscript is in press! @Marypenckofer led this analysis evaluating disparities in stroke recurrence among Medicaid/pending/no insurance as compared to Private/VA beneficiaries, with more pronounced disparities among: 🚩 Men 🚩 The young 🚩 Mild deficits
1
2
10
527
Jim Brorson @UChicago_Neuro and many other unsung heroes of the CASPR collab!
1
101
Been saying it for years...statin in the water supply. For healthy, elderly adults, atorvastatin reduces cardiac event risk! STAREE trial @NEJM nejm.org/doi/full/10.1056/NE… NNT 200 @ 1yr 🟢 Men benefit more than women 🟢 Benefit despite (1) "normal" BP and (2) "good" LDL 👇
2
1
294
The "silent killer", hypertension. ✅ #1 risk factor for stroke in the US ✅ Recognition of HTN led to 🔻 in stroke by half in the 20th century ✅ Should ALWAYS be something you discuss with your patient, whether you're a chiropractor, podiatrist, or cardiologist ❤️
Hypertension remains a major public health challenge in the United States, affecting more than 120 million adults with low rates of control, and is a central strategic priority of the American Heart Association as a leading, preventable driver of cardiovascular morbidity and mortality. This science advisory presents the American Heart Association Blood Pressure Control Logic Model as a unifying framework to coordinate and scale multi-sector efforts to improve blood pressure control across health care and community settings. Sustained improvements in blood pressure control and reductions in cardiovascular events require ongoing multi-sector collaboration, rigorous evaluation, and adaptation of the Logic Model to diverse organizations and communities. 📷 The American Heart Association blood pressure control logic model professional.heart.org/en/sc…
1
1
441
Jim Siegler, MD, FAHA retweeted
- ESUS 2.0 carries a lower recurrence risk (~1%) - Incomplete diagnostic evaluation after ESUS is associated with increased recurrence - If you find cancer or athero as a potential mechanism in ESUS, recurrence risk is increased ahajournals.org/doi/10.1161/… ahajournals.org/doi/10.1161/…
1
30
63
3,248
Current LDL lowering therapy paradigms are “biologically backward”. Waiting for a clinical event while silent athero accumulates over years before intervention results in heightened individual and population risk. Cost effectiveness analyses are needed to confirm.
Editorial at #ESCCongress on #VESALIUSCV: waiting for a heart attack or stroke before intensifying LDL-lowering is biologically backwards — that event marks prevention's failure, not its starting point. The best way to prevent the last ... ahajrnls.org/4zNCM5e @DrMichaelShapir
1
401
Jim Siegler, MD, FAHA retweeted
Using an institutional registry, the investigators derived the MAD-MT score — a pragmatic tool that identifies DMVO patients most likely to benefit from EVT while minimizing risk, supporting future trial design. #stroke ahajournals.org/doi/full/10.…
2
17
1
38
3,587